Impact Factor
4.06
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.52
1,628 total citations
h5-index
57
h5 depth signal
Cited share
74.7%
227 of 304
Total citations
1,628
Citation footprint
Metric signal
5.68
External metric anchor
Self-citation
2.1%
34 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,156
Canada
150
United Kingdom
150
Germany
119
Italy
106
Citing Fields of Research
Cardiology
1,390
Physiology
130
Transplantation
117
Respiratory Support
108
Auto-Inflammatory Disorders
67
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,789
Articles tracked across the journal lifetime
Indexed publication set
304
227 cited publications
Last 12 months
234
19.5 publications/month
Open access share
17.1%
40 OA publications in the last year
Leading citing country
United States
1,156 citing publications
Leading citing field
Cardiology
1,390 citing publications
Latest tracked publication
21 September 2026
10 recent records available
Coverage & Indexing History
v1n1, May 2008-
v1n1, May 2008-
Research Focus & Classification
Indexed Subjects
Cardiology
Issuing & Sponsoring Bodies
Contributor
American Heart Association
Broad Categories
Cardiology
Vascular Diseases
MeSH Descriptors
Heart Failure
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1161/circheartfailure.126.014345
Open DOI
Clonal Hematopoiesis of Indeterminate Potential Proteomic Risk Score for Predicting Clinical Outcome in Patients With Heart Failure With Preserved Ejection Fraction
BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP) is common in heart failure with preserved ejection fraction (HFpEF). However, the proteomic signatures linked to CHIP driver mutations and their prognostic implications i...
02
DOI 10.1161/circheartfailure.125.013871
Open DOI
Health-Related Quality of Life in Older Patients With Advanced Heart Failure From Before to 2 Years After Heart Transplantation or Long-Term Mechanical Circulatory Support: Findings From the SUSTAIN-IT Study
BACKGROUND: Health-related quality of life (HRQOL) is a key consideration among older patients with heart failure considering advanced therapies. We evaluated change in HRQOL from before to 24 months after heart transplantation (HT) or l...
03
DOI 10.1161/circheartfailure.125.013822
Open DOI
Optimizing Screening Intervals for At-Risk Relatives of Dilated Cardiomyopathy Carrying a TTNtv
BACKGROUND: Cardiomyopathy guidelines recommend routine screening of at-risk relatives with dilated cardiomyopathy (DCM). Titin-truncating variants are the most prevalent cause. However, the diagnostic yield of screening is low. Risk-bas...
04
DOI 10.1161/circheartfailure.126.014265
Open DOI
Heart Failure and Neurocognitive Disorders: A Narrative Review
Neurocognitive disorders—including mild cognitive impairment, dementia, and delirium—are common yet often underrecognized in heart failure, impairing self-care and outcomes. These heart failure–related neurocognitive disorders pose a sig...
05
DOI 10.1161/circheartfailure.126.014894
Open DOI
Disentangling Pulmonary Vascular Phenotypes in Group 2 Pulmonary Hypertension Using Bioactive Lipid Profiling
06
DOI 10.1161/circheartfailure.126.014184
Open DOI
Management and Outcomes of Cardiac Sarcoidosis: Insights From the Nationwide MYSTICS Registry
BACKGROUND: Cardiac sarcoidosis (CS) may lead to serious outcomes, but large-scale data are lacking because of its rarity, diagnostic uncertainty, and heterogeneous clinical presentations. Actual management and outcomes, including recurr...
07
DOI 10.1161/circheartfailure.125.014322
Open DOI
Atrial Fibrillation in Genotyped Dilated Cardiomyopathy: Epidemiology, Risk Factors, and Outcomes: Insights From the SHaRe Registry
BACKGROUND: Atrial fibrillation (AF) is the most common arrhythmia in dilated cardiomyopathy (DCM) and is associated with adverse outcomes. However, the genetic determinants of AF risk and its prognostic significance across genotyped DCM...
08
DOI 10.1161/circheartfailure.125.014148
Open DOI
Cardiac Resynchronization Therapy and Circulating Metabolomic Profile in Patients With Advanced Heart Failure
BACKGROUND: It is unknown whether cardiac resynchronization therapy (CRT) improves systemic metabolomic profile by enhancing left ventricular function. The observational cohort study aimed to investigate the effect of CRT on left ventric...
09
DOI 10.1161/circheartfailure.125.014073
Open DOI
Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension
BACKGROUND: Pulmonary hypertension (PH) due to left-sided heart disease (Group 2 PH) is the most common type of PH and comprises 2 subtypes with distinct clinical profiles and outcomes: isolated postcapillary PH and combined pre- and pos...
10
DOI 10.1161/circheartfailure.125.014037
Open DOI
Changes in Hemodynamic and Inferior Vena Cava Parameters during Supine and Upright Exercise in a Patient With a Left Ventricular Assisted Device
Bibliographical & Catalog Notes
Description based on first issue; title from cover.
Print issues ceased with v. 5, no. 6 (2012).
Also issued online.